BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8106120)

  • 21. Ultradian oscillation in somatostatin binding in the arcuate nucleus of adult male rats.
    Tannenbaum GS; Farhadi-Jou F; Beaudet A
    Endocrinology; 1993 Sep; 133(3):1029-34. PubMed ID: 8103446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of food deprivation in the rat on hypothalamic expression of growth hormone-releasing factor and somatostatin.
    Bruno JF; Olchovsky D; White JD; Leidy JW; Song J; Berelowitz M
    Endocrinology; 1990 Nov; 127(5):2111-6. PubMed ID: 1977579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence.
    Aguila MC; Milenkovic L; McCann SM; Snyder GD
    Neuroendocrinology; 1990 Sep; 52(3):238-42. PubMed ID: 1977095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation.
    Arsenijevic Y; Rivest RW; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibition of growth hormone release by gastrin-releasing peptide involves somatostatin release.
    Kentroti S; Aguila MC; McCann SM
    Endocrinology; 1988 Jun; 122(6):2407-11. PubMed ID: 2897283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.
    Tannenbaum GS; Ling N
    Endocrinology; 1984 Nov; 115(5):1952-7. PubMed ID: 6149116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effects of somatostatin on in vitro growth hormone release in two porcine breeds with different growth rates.
    Torronteras R; Gracia-Navarro F; Elsaesser F
    J Neuroendocrinol; 1996 Dec; 8(12):891-900. PubMed ID: 8953466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition.
    Kraicer J; Cowan JS; Sheppard MS; Lussier B; Moor BC
    Endocrinology; 1986 Nov; 119(5):2047-51. PubMed ID: 2876882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro.
    Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS
    Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion.
    Turner JP; Tannenbaum GS
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E683-90. PubMed ID: 7485482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries.
    Goodyer CG; Branchaud CL; Lefebvre Y
    J Clin Endocrinol Metab; 1993 May; 76(5):1259-64. PubMed ID: 8098715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    Lamberts SW; Verleun T; Oosterom R
    J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat.
    Katakami H; Downs TR; Frohman LA
    Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin-stimulated growth hormone-releasing factor secretion in vitro is modified by fetal ethanol exposure.
    Conway S; Swain R
    Alcohol Clin Exp Res; 1997 Jun; 21(4):703-9. PubMed ID: 9194927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the glucose-dependent release of growth hormone-releasing factor and somatostatin from superfused rat hypothalami.
    Baes M; Vale WW
    Neuroendocrinology; 1990 Feb; 51(2):202-7. PubMed ID: 1968236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H; Suzuki M
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological role of growth hormone (GH)-releasing factor and somatostatin in the dynamics of GH secretion in adult male rat.
    Sato M; Takahara J; Fujioka Y; Niimi M; Irino S
    Endocrinology; 1988 Oct; 123(4):1928-33. PubMed ID: 2901340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of growth hormone-releasing factor (1-44) on growth hormone release from human somatotrophinomas in vitro: interaction with somatostatin, dopamine, vasoactive intestinal peptide and cycloheximide.
    White MC; Daniels M; Kendall-Taylor P; Turner SJ; Mathias D; Teasdale G
    J Endocrinol; 1985 May; 105(2):269-76. PubMed ID: 2859345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic preprosomatostatin messenger ribonucleic acid expression in mice transgenic for excess or deficient endogenous growth hormone.
    Hurley DL; Phelps CJ
    Endocrinology; 1992 Apr; 130(4):1809-15. PubMed ID: 1347738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.